Viridium Announces Changes to Board of Directors

Loading...
Loading...

VANCOUVER, BC / ACCESSWIRE / October 25, 2018 / ViridiumPacific Group Ltd. ("Viridium" or the "Company") VIR VIRFFis pleased to announce the appointment of Jay Garnett, President and ChiefExecutive Officer of Viridium, to the Board of Directors of the Company,effective October 23, 2018.

BettyDusange-Hayer has graciously stepped down from her role as Director on theBoard of Viridium, effective October 23, 2018, in order to accommodate Jay'sDirector position for the Company. Ms. Dusange-Hayer has served as a Director sincethe Company became publicly listed on October 10, 2017 and has been an activeBoard member servicing several committees and contributing to the Company'sdevelopment.

"Wethank Betty for her contribution to Viridium over the past year and wish herall the best in her future endeavours. Viridium was fortunate to have anindividual with the intelligence and government and industry connections asBetty on the team," said Harry McWaters, Chairman of the Board of Directors ofViridium.

About Viridium

ViridiumPacific Group Ltd. is a consumer wellness and biotech innovation company basedin British Columbia, and the parent company of operating subsidiaries involvedin horticultural production, (Experion Biotechologies Inc.) propertydevelopment (Fish Trap Ventures Ltd.), and human resource management (StaveLake Services Ltd.) Experion Biotechnologies Inc., is a Health Canada licensedproducer of cannabis, which operates in an 8,300 square-foot indoor facility outsideof Mission, BC.

Moreinformation about Viridium can be found under the Company's profile on SEDARat www.sedar.com.

For further information:

Renmark Financial Communications Inc.
MelanieBarbeau: mbarbeau@renmarkfinancial.com
Tel:(416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

Loading...
Loading...

Disclosure

This press release containsforward-looking information within the meaning of Canadian securities laws. Althoughthe Company believes that such information is reasonable, it can give noassurance that such expectations will prove to be correct.

Forward looking information istypically identified by words such as: believe, expect, anticipate, intend,estimate, forecast, postulate and similar expressions, or are those, which, bytheir nature, refer to future events. The Company cautions investors that anyforward-looking information provided by the Company are not guarantees offuture results or performance, and that actual results may differ materiallyfrom those in forward looking information as a result of various factors,including, but not limited to: the state of the financial markets for theCompany's equity securities; recent market volatility; the Company's ability toraise the necessary capital or to be fully able to implement its businessstrategies; the risks identified in the Filing Statement, and other risks andfactors that the Company is unaware of at this time. The reader is referred to theFiling Statement dated September 25, 2017 and/or the most recent annual andinterim Management's Discussion and Analysis for a more complete discussion ofsuch risk factors and their potential effects, copies of which may be accessedthrough the Company page on SEDAR at www.sedar.com.

SOURCE: Viridium Pacific Group Ltd.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsManagementPress ReleasesHealthcare & Pharmaceutical
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...